These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23324513)

  • 1. Antidepressant-selective gynecomastia.
    Kaufman KR; Podolsky D; Greenman D; Madraswala R
    Ann Pharmacother; 2013 Jan; 47(1):e6. PubMed ID: 23324513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gynecomastia possibly induced by rosuvastatin.
    Oteri A; Catania MA; Travaglini R; Russo A; Giustini SE; Caputi AP; Polimeni G
    Pharmacotherapy; 2008 Apr; 28(4):549-51. PubMed ID: 18363539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open-label study of duloxetine for the treatment of major depressive disorder: comparison of switching versus initiating treatment approaches.
    Wohlreich MM; Martinez JM; Mallinckrodt CH; Prakash A; Watkin JG; Fava M
    J Clin Psychopharmacol; 2005 Dec; 25(6):552-60. PubMed ID: 16282837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
    Lin CH; Lin SH; Jang FL
    J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy, safety and tolerability of duloxetine 60 mg once daily in major depression.
    Cowen PJ; Ogilvie AD; Gama J
    Curr Med Res Opin; 2005 Mar; 21(3):345-56. PubMed ID: 15811202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative, randomized, double-blind study of trazodone prolonged-release and sertraline in the treatment of major depressive disorder.
    Munizza C; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2006 Sep; 22(9):1703-13. PubMed ID: 16968574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorder.
    Perahia DG; Kajdasz DK; Desaiah D; Haddad PM
    J Affect Disord; 2005 Dec; 89(1-3):207-12. PubMed ID: 16266753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ; Stewart JW; McGrath PJ; Deliyannides DA; Batchelder ST; Black SR; Withers A; O'Shea D; Chen Y
    J Clin Psychiatry; 2012 Jul; 73(7):984-91. PubMed ID: 22901348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duloxetine: review of its pharmacology, and therapeutic use in depression and other psychiatric disorders.
    Gupta S; Nihalani N; Masand P
    Ann Clin Psychiatry; 2007; 19(2):125-32. PubMed ID: 17612852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine in the treatment of major psychiatric and neuropathic disorders.
    Müller N; Schennach R; Riedel M; Möller HJ
    Expert Rev Neurother; 2008 Apr; 8(4):527-36. PubMed ID: 18416656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visual hallucinations during duloxetine treatment in a patient with major depressive disorder.
    Tomita T; Yasui-Furukori N; Kaneko S
    Clin Neuropharmacol; 2013; 36(5):175-6. PubMed ID: 24045610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Duloxetine-related tardive dystonia and tardive dyskinesia: a case report.
    Chen PY; Lin PY; Tien SC; Chang YY; Lee Y
    Gen Hosp Psychiatry; 2010; 32(6):646.e9-646.e11. PubMed ID: 21112461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tachyphylaxis after repeated antidepressant drug exposure in patients with recurrent major depressive disorder.
    Amsterdam JD; Williams D; Michelson D; Adler LA; Dunner DL; Nierenberg AA; Reimherr FW; Schatzberg AF
    Neuropsychobiology; 2009; 59(4):227-33. PubMed ID: 19571597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation.
    Licht RW; Qvitzau S
    Psychopharmacology (Berl); 2002 May; 161(2):143-51. PubMed ID: 11981594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year efficacy and safety of rosuvastatin + fenofibric acid combination therapy in patients with mixed dyslipidemia: evaluation of dose response.
    Ferdinand KC; Davidson MH; Kelly MT; Setze CM
    Am J Cardiovasc Drugs; 2012 Apr; 12(2):117-25. PubMed ID: 22263674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders.
    Ramasubbu R
    Acta Psychiatr Scand; 2001 Sep; 104(3):236-8; discusiion 238-9. PubMed ID: 11531662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.